Piscataway, NJ, October 28, 2021– Camber Pharmaceuticals is pleased to announce it has recently added 4 products to its’ Copay Card Program, which will save patients a substantial amount of money each year. The products include:
- Deferasirox tablets
- Dimethyl Fumarate capsules
- Droxidopa capsules
- Vigabatrin oral solution
“Camber’s Copay Card Program is designed to help patients by increasing access to affordable medicines and improving health outcomes” stated Kon Ostaficiuk, President of Camber.
Numerous studies have shown prescription copayments are a major incentive to drug adherence. In some cases, patients never fill prescriptions or ration medicine or doses to save money.
“Adding these prescriptions to a copay plan makes Camber’s products very attractive to patients and retailers alike. With many prescription drug insurance plans, the patient could have little-to-no copayment,” Kon added. “We hope this brings financial relief to more patients and encourages them follow their healthcare provider’s advice.”
Deferasirox Tablets: Deferasirox is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old.
Learn more at https://www.camberpharma.com/products/deferasirox/.
Dimethyl Fumarate DR Capsules: Dimethyl Fumarate is indicated for the treatment of relapsing forms of multiple sclerosis (MS).
Learn more at https://www.camberpharma.com/products/dimethyl-fumarate/.
Droxidopa Capsules: Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a certain medical condition, (neurogenic orthostatic hypotension)
Learn more at https://www.camberpharma.com/products/droxidopa/.
Vigabatrin Oral Solution: Vigabatrin is used in combination with other medications to treat seizure disorders.
Learn more at https://www.camberpharma.com/products/vigabatrin/.
For more information about Camber’s copay card program, please visit www.CamberPharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®